Source-grounded facts extracted from NU SKIN ENTERPRISES, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NU SKIN ENTERPRISES, INC. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026 at the 2026-05-28 meeting.
“Ratification of PricewaterhouseCoopers LLP 38,798,633 970,082 65,184 0”
NU SKIN ENTERPRISES, INC. shareholders approved Approval of the Company’s Amended and Restated 2024 Omnibus Incentive Plan at the 2026-05-28 meeting.
“Approval of the Amended and Restated 2024 Omnibus Incentive Plan 24,185,333 10,177,825 40,483 5,430,258”
NU SKIN ENTERPRISES, INC. shareholders approved Advisory approval of the Company’s executive compensation at the 2026-05-28 meeting.
“Advisory Approval of the Company’s Executive Compensation 33,111,458 1,255,101 37,082 5,430,258”
NU SKIN ENTERPRISES, INC. shareholders approved Election of nine directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal at the 2026-05-28 meeting.
“Election of Directors Emma S. Battle 33,948,833 403,121 51,687 5,430,258 Daniel W. Campbell 33,978,430 298,746 126,465 5,430,258 Steven J. Lund 33,854,219 520,147 29,275 5,430,258 Ryan S. Napierski 34,083,028 289,928 30,685 5,430,258 Laura Nathanson 33,593,418 767,205 43,018 5,430,258 Thomas R. Pisano 34,078,549 279,972 45,120 5,430,258 James M. Winett 34,027,452 330,366 45,823 5,430,258 Edwina D. Woodbury 33,953,493 399,800 50,348 5,430,258 Mark A. Zorko 34,036,158 322,233 45,250 5,430,258”
Steven K. Hatchett resigned as Executive Vice President and Chief Product Officer at NU SKIN ENTERPRISES, INC..
“Steven K. Hatchett notified the Company that, due to family health circumstances, he determined to resign from his position as Executive Vice President and Chief Product Officer, effective as of May 8, 2026.”
NU SKIN ENTERPRISES, INC. reported the three-month period ended March 31, 2026 results: revenue $320.6 million, EPS $0.04 or $0.14 excluding certain charges. Guidance reaffirmed.
“7, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter revenue results within its guidance range. Executive Summary Q1 2026 vs. Prior-year Quarter Revenue $320.6 million; (12.0)% • +1.1% FX impact or $3.9 million Earnings Per Share (EPS) $0.04 or $0.14 excluding certain charges compared to $2.14 or $0.23 excluding one-time gain from Mavely sale”
NU SKIN ENTERPRISES, INC. incurred credit facility of $175 million term loan facility and a $75 million revolving credit facility with Bank of America, N.A. at Term SOFR plus an initial spread of 1.75% per annum maturing five years.
“The Credit Agreement provides for a $175 million term loan facility and a $75 million revolving credit facility, each with a term of five years”
NU SKIN ENTERPRISES, INC. amended Credit Agreement with Bank of America, N.A., as Administrative Agent, and the Lenders from time to time party thereto valued at $175 million term loan facility and a $75 million revolving credit facility (effective 2026-03-27).
“On March 27, 2026 (the “Closing Date”), Nu Skin Enterprises, Inc. (the “Company”) entered into that certain Second Amendment and Restatement Agreement in connection with the Second Amended and Restated Credit Agreement (the “Credit Agreement”) by and among the Company, as Borrower, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent, which amends and restates the Company’s existing amended and restated credit agreement, dated as of June 14, 2022 (as amended, supplemented or otherwise modified prior to the Closing Date, the “Existing Credit Agreement”).”
Zheqing (Simon) Shen departed as Director at NU SKIN ENTERPRISES, INC..
“On March 5, 2025, Zheqing (Simon) Shen informed Nu Skin Enterprises, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) at the Company’s 2025 Annual Meeting of Stockholders due to other professional commitments.”
NU SKIN ENTERPRISES, INC. completed a disposition involving Clout.io Holdings, Inc. for $230 million in cash, subject to certain adjustments (closed 2025-01-02).
“limited liability company (“ Mavely ”), pursuant to which, among other things, Purchaser purchased all of Seller’s equity in Mavely for total consideration consisting of $230 million in cash, subject to certain adjustments as set forth in the Purchase Agreement, including post-closing determination of net working capital and other elements of the purchase”
NU SKIN ENTERPRISES, INC.: Amended and restated bylaws to update procedural and disclosure requirements for stockholder nominations and proposals, and other clarifications (effective 2024-10-31).
“On October 31, 2024, the Board of Directors of Nu Skin Enterprises, Inc. (the “Company”) approved and adopted the Sixth Amended and Restated Bylaws of the Company (as so amended and restated, the “Bylaws”), which became effective upon such approval and adoption.”
Mark A. Zorko was appointed as Director at NU SKIN ENTERPRISES, INC..
“On September 10, 2024, the Board of Directors (the “Board”) of Nu Skin Enterprises, Inc. (the “Company”) appointed Mark A. Zorko as a director of the Company”
NU SKIN ENTERPRISES, INC. reported the three-month period ended March 31, 2024 results: revenue $417.3 million, EPS $(0.01) or $0.09 excluding restructuring charges. Guidance reaffirmed.
“Nu Skin Enterprises Reports First Quarter Results PROVO, Utah — May 8, 2024 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter results in line with guidance. Executive Summary Q1 2024 vs. Prior-year Quarter Revenue $417.3 million; (13.3)% • (3.8)% FX impact or $(18.2) million • Rhyz revenue $62.5 million; 57.5% Earnings Per Share (EPS) $(0.01) or $0.09 excluding restructuring charges compared to $0.23 or $0.37 excluding restructuring charges Customers 875,261; (19)% Paid Affiliates 154,171; (30)% or (14)% excluding an adjustment to eligibility requirements Sales Leaders 38,609; (12)%”
Andrew Lipman retired as Director at NU SKIN ENTERPRISES, INC..
“On March 15, 2024, Andrew Lipman informed Nu Skin Enterprises, Inc. (the “Company”) that he has decided to retire from the Company’s Board of Directors (the “Board”) and will not stand for re-election to the Board at the Company’s 2024 Annual Meeting of Stockholders.”
NU SKIN ENTERPRISES, INC. reported Full-year 2024 results: revenue $1.73 to $1.87 billion, EPS $0.75 to $1.15 or $0.95 to $1.35 non-GAAP. Guidance reaffirmed.
“2024 Revenue $1.73 to $1.87 billion; (12)% to (5)% • Approximately (1)% FX impact 2024 EPS $0.75 to $1.15 or $0.95 to $1.35 non-GAAP”
NU SKIN ENTERPRISES, INC. reported Q1 2024 results: revenue $400 to $435 million, EPS $(0.07) to $0.03. Guidance reaffirmed.
“Q1 2024 Revenue $400 to $435 million; (17)% to (10)% • Approximately (3) to (2)% FX impact Q1 2024 EPS $(0.07) to $0.03 or $0.00 to $0.10 non-GAAP”
NU SKIN ENTERPRISES, INC. reported financial results for the three-month and annual periods ended December 31, 2023.
“On February 14, 2024, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month and annual periods ended December 31, 2023, and certain other information.”
Joseph Chang departed as Chief Scientific Officer at NU SKIN ENTERPRISES, INC..
“Joseph Chang informed Nu Skin Enterprises, Inc. (the “Company”) that he will be stepping down from his role as Chief Scientific Officer as of March 30, 2024.”
NU SKIN ENTERPRISES, INC.: Board adopted Fifth Amended and Restated Bylaws effective February 5, 2024, with updates to align with DGCL, proxy rules, advance notice procedures, and director resignation requirements (effective 2024-02-05).
“On February 5, 2024, the Board of Directors of Nu Skin Enterprises, Inc. (the “Company”) approved and adopted the Fifth Amended and Restated Bylaws of the Company (as so amended and restated, the “Bylaws”), which became effective upon such approval and adoption.”
NU SKIN ENTERPRISES, INC. reported third quarter 2023 results: revenue $498.8 million, EPS $(0.74). Guidance reaffirmed.
“Results PROVO, Utah — Nov. 1, 2023 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter 2023 results. Executive Summary Q3 2023 vs. Prior-year Quarter Revenue $498.8 million; (7)% • (1)% FX impact or $(8.1) million Earnings Per Share (EPS) $(0.74) or $0.56 excluding an inventory write-off compared to $(0.51) or $0.47 excluding restructuring and”
NU SKIN ENTERPRISES, INC. announced a restructuring with charges of $15–$25 million in severance charges (workforce reductions).
“On October 27, 2023, the Company adopted a strategic plan to focus resources on the Company’s global priorities and optimize future growth and profitability (the “global program”). The global program includes workforce reductions. The Company estimates total charges for the fourth quarter of 2023 under the global program will approximate $15–$25 million in severance charges, which will be paid in cash.”
Connie Tang resigned as Executive Vice President and Chief Global Growth and Customer Experience Officer at NU SKIN ENTERPRISES, INC..
“Connie Tang notified the Company that, due to family health reasons, she determined to resign from her position as Executive Vice President and Chief Global Growth and Customer Experience Officer, effective October 31, 2023.”
NU SKIN ENTERPRISES, INC. reported second quarter 2023 results: revenue $500.3 million, EPS $0.54. Guidance lowered.
“today announced second quarter 2023 results in line with expectations. Executive Summary Q2 2023 vs. Prior-year Quarter Revenue: $500.3 million; (11)% • (3)% FX impact or $(16.4) million Earnings Per Share (EPS): $0.54”
James D. Thomas was appointed as Executive Vice President and Chief Financial Officer at NU SKIN ENTERPRISES, INC..
“On July 24, 2023, following a search that included internal and external candidates, the Company’s Board of Directors appointed James D. Thomas as Executive Vice President and Chief Financial Officer on a permanent basis.”
NU SKIN ENTERPRISES, INC. shareholders approved Advisory Vote on the Frequency of Future Stockholder Advisory Votes on the Company’s Executive Compensation at the 2023-06-07 meeting.
“Advisory Vote on the Frequency of Future Stockholder Advisory Votes on the Company’s Executive Compensation 38,657,844 1,776,736 2,458,877 14,964 2,696,438”
NU SKIN ENTERPRISES, INC. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-07 meeting.
“Ratification of PricewaterhouseCoopers LLP 44,751,013 829,330 24,516 0”
NU SKIN ENTERPRISES, INC. shareholders approved Advisory approval of the Company’s executive compensation at the 2023-06-07 meeting.
“Advisory Approval of the Company’s Executive Compensation 42,369,023 507,952 31,446 2,696,438”
NU SKIN ENTERPRISES, INC. shareholders approved Election of nine directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal at the 2023-06-07 meeting.
“Election of nine directors to serve until their successors are duly elected and qualified at the next annual meeting of stockholders or until their earlier death, resignation or removal”
NU SKIN ENTERPRISES, INC. updated its first quarter 2023 guidance (reaffirmed).
“On May 3, 2023, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month period ended March 31, 2023, and certain other information. A copy of the press release is attached as Exhibit 99.1 to this report.”
James D. Thomas was appointed as Interim CFO at NU SKIN ENTERPRISES, INC..
“On March 30, 2023, the Company’s Board of Directors appointed James D. Thomas, the Company’s Senior Vice President and Chief Accounting Officer, as Interim CFO, effective upon Mr. Lawrence’s departure as CFO.”
Mark H. Lawrence resigned as Executive Vice President and Chief Financial Officer at NU SKIN ENTERPRISES, INC..
“On March 24, 2023, Mark H. Lawrence notified Nu Skin Enterprises, Inc. (the “Company”) of his resignation from his position as Executive Vice President and Chief Financial Officer.”
NU SKIN ENTERPRISES, INC. reported financial results for three-month and annual periods ended December 31, 2022.
“On February 15, 2023, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three-month and annual periods ended December 31, 2022, and certain other information.”
NU SKIN ENTERPRISES, INC. reported financial results for the three- and nine-month periods ended September 30, 2022.
“On November 2, 2022, Nu Skin Enterprises, Inc. (the “Company”) issued a press release announcing its financial results for the three- and nine-month periods ended September 30, 2022, and certain other information.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.